Benign prostatic hypertrophy: update on drug therapy

Can Fam Physician. 2006 Sep;52(9):1075-6, 1077-8.
[Article in English, French]
No abstract available

MeSH terms

  • Aged
  • Androgen Antagonists / adverse effects
  • Androgen Antagonists / therapeutic use*
  • Azasteroids / adverse effects
  • Azasteroids / therapeutic use
  • Canada
  • Dose-Response Relationship, Drug
  • Dutasteride
  • Enzyme Inhibitors / adverse effects
  • Enzyme Inhibitors / therapeutic use
  • Finasteride / adverse effects
  • Finasteride / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Prostatic Hyperplasia / diagnosis
  • Prostatic Hyperplasia / drug therapy*
  • Randomized Controlled Trials as Topic
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Androgen Antagonists
  • Azasteroids
  • Enzyme Inhibitors
  • Finasteride
  • Dutasteride